Sectra AB (publ) (SECT-B.ST)
SEK 274.3
(0.94%)
SEK 274.3
(0.94%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 39.06 Million SEK | -97.69% |
| 2022 | 1.68 Billion SEK | 27.48% |
| 2021 | 1.32 Billion SEK | 16.93% |
| 2020 | 1.13 Billion SEK | -2.45% |
| 2019 | 1.16 Billion SEK | 20.8% |
| 2018 | 960.79 Million SEK | 10.71% |
| 2017 | 867.83 Million SEK | 8.0% |
| 2016 | 803.57 Million SEK | 1.97% |
| 2015 | 788.08 Million SEK | 14.08% |
| 2014 | 690.82 Million SEK | 11.46% |
| 2013 | 619.79 Million SEK | 0.54% |
| 2012 | 616.46 Million SEK | 7.81% |
| 2011 | 571.83 Million SEK | -36.65% |
| 2010 | 902.64 Million SEK | 8.71% |
| 2009 | 830.3 Million SEK | 32.19% |
| 2008 | 628.11 Million SEK | 28.91% |
| 2007 | 487.23 Million SEK | 960.06% |
| 2006 | -56.65 Million SEK | -188.24% |
| 2005 | -19.65 Million SEK | -104.29% |
| 2004 | 458.36 Million SEK | 13.68% |
| 2003 | 403.21 Million SEK | -3.36% |
| 2002 | 417.24 Million SEK | 33.02% |
| 2001 | 313.68 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 11 Million SEK | 5150.92% |
| 2023 Q4 | 10.16 Million SEK | -2.28% |
| 2023 Q3 | 10.4 Million SEK | -97.92% |
| 2023 Q1 | 461.31 Million SEK | 4.29% |
| 2023 FY | 39.06 Million SEK | -97.69% |
| 2023 Q2 | 500.99 Million SEK | 8.6% |
| 2022 Q1 | 383.04 Million SEK | -1.91% |
| 2022 Q3 | 454.38 Million SEK | 11.34% |
| 2022 FY | 1.68 Billion SEK | 27.48% |
| 2022 Q2 | 408.1 Million SEK | 6.54% |
| 2022 Q4 | 442.33 Million SEK | -2.65% |
| 2021 Q4 | 390.52 Million SEK | 12.25% |
| 2021 Q1 | 281.36 Million SEK | -12.86% |
| 2021 FY | 1.32 Billion SEK | 16.93% |
| 2021 Q2 | 304.2 Million SEK | 8.12% |
| 2021 Q3 | 347.89 Million SEK | 14.36% |
| 2020 Q2 | 278.56 Million SEK | 13.9% |
| 2020 Q1 | 244.56 Million SEK | -25.04% |
| 2020 Q3 | 286.22 Million SEK | 2.75% |
| 2020 Q4 | 322.89 Million SEK | 12.81% |
| 2020 FY | 1.13 Billion SEK | -2.45% |
| 2019 FY | 1.16 Billion SEK | 20.8% |
| 2019 Q1 | 262.15 Million SEK | 4.72% |
| 2019 Q2 | 273.97 Million SEK | 4.51% |
| 2019 Q3 | 298.29 Million SEK | 8.88% |
| 2019 Q4 | 326.24 Million SEK | 9.37% |
| 2018 Q1 | 222.54 Million SEK | -8.19% |
| 2018 FY | 960.79 Million SEK | 10.71% |
| 2018 Q4 | 250.34 Million SEK | 0.52% |
| 2018 Q3 | 249.05 Million SEK | 4.27% |
| 2018 Q2 | 238.85 Million SEK | 7.33% |
| 2017 Q3 | 225.06 Million SEK | 6.42% |
| 2017 Q4 | 242.4 Million SEK | 7.7% |
| 2017 Q1 | 189.38 Million SEK | -10.51% |
| 2017 Q2 | 211.49 Million SEK | 11.67% |
| 2017 FY | 867.83 Million SEK | 8.0% |
| 2016 Q1 | 173.64 Million SEK | -18.58% |
| 2016 Q3 | 222.93 Million SEK | 14.11% |
| 2016 Q4 | 211.63 Million SEK | -5.07% |
| 2016 Q2 | 195.36 Million SEK | 12.51% |
| 2016 FY | 803.57 Million SEK | 1.97% |
| 2015 Q1 | 178.16 Million SEK | -11.44% |
| 2015 FY | 788.08 Million SEK | 14.08% |
| 2015 Q4 | 213.26 Million SEK | 2.96% |
| 2015 Q2 | 189.5 Million SEK | 6.36% |
| 2015 Q3 | 207.14 Million SEK | 9.31% |
| 2014 FY | 690.82 Million SEK | 11.46% |
| 2014 Q1 | 148.51 Million SEK | -16.2% |
| 2014 Q2 | 163.24 Million SEK | 9.92% |
| 2014 Q4 | 201.17 Million SEK | 13.09% |
| 2014 Q3 | 177.89 Million SEK | 8.97% |
| 2013 Q4 | 177.22 Million SEK | 13.16% |
| 2013 Q3 | 156.61 Million SEK | 6.54% |
| 2013 Q1 | 138.96 Million SEK | -12.8% |
| 2013 Q2 | 146.99 Million SEK | 5.78% |
| 2013 FY | 619.79 Million SEK | 0.54% |
| 2012 Q2 | 145.68 Million SEK | -2.58% |
| 2012 Q1 | 149.54 Million SEK | -40.51% |
| 2012 FY | 616.46 Million SEK | 7.81% |
| 2012 Q4 | 159.36 Million SEK | -1.55% |
| 2012 Q3 | 161.86 Million SEK | 11.11% |
| 2011 Q2 | 140.39 Million SEK | 6.39% |
| 2011 Q3 | 111.75 Million SEK | -20.4% |
| 2011 Q4 | 251.37 Million SEK | 124.93% |
| 2011 FY | 571.83 Million SEK | -36.65% |
| 2011 Q1 | 131.95 Million SEK | -35.62% |
| 2010 Q1 | 210.85 Million SEK | -11.07% |
| 2010 Q3 | 242.03 Million SEK | -1.13% |
| 2010 FY | 902.64 Million SEK | 8.71% |
| 2010 Q4 | 204.95 Million SEK | -15.32% |
| 2010 Q2 | 244.8 Million SEK | 16.1% |
| 2009 Q4 | 237.09 Million SEK | 14.35% |
| 2009 FY | 830.3 Million SEK | 32.19% |
| 2009 Q1 | 192.42 Million SEK | 0.0% |
| 2009 Q2 | 193.45 Million SEK | 0.53% |
| 2009 Q3 | 207.33 Million SEK | 7.18% |
| 2008 FY | 628.11 Million SEK | 28.91% |
| 2007 FY | 487.23 Million SEK | 960.06% |
| 2006 FY | -56.65 Million SEK | -188.24% |
| 2005 FY | -19.65 Million SEK | -104.29% |
| 2004 FY | 458.36 Million SEK | 13.68% |
| 2003 FY | 403.21 Million SEK | -3.36% |
| 2002 FY | 417.24 Million SEK | 33.02% |
| 2001 FY | 313.68 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acarix AB (publ) | 82.85 Million SEK | 52.851% |
| ADDvise Group AB (publ) | 611.8 Million SEK | 93.615% |
| ADDvise Group AB (publ) | 611.8 Million SEK | 93.615% |
| Arcoma AB | 53.25 Million SEK | 26.645% |
| Bactiguard Holding AB (publ) | 4.96 Million SEK | -686.134% |
| BICO Group AB (publ) | 2.84 Billion SEK | 98.629% |
| Boule Diagnostics AB (publ) | 210.44 Million SEK | 81.438% |
| CellaVision AB (publ) | 295.99 Million SEK | 86.803% |
| Clinical Laserthermia Systems AB (publ) | 68.93 Million SEK | 43.329% |
| Chordate Medical Holding AB (publ) | 1.3 Million SEK | -2883.769% |
| C-Rad AB (publ) | 3.8 Million SEK | -927.974% |
| Duearity AB (publ) | 21.58 Million SEK | -80.973% |
| Dignitana AB (publ) | 74.73 Million SEK | 47.732% |
| Episurf Medical AB (publ) | 2.7 Million SEK | -1346.778% |
| Getinge AB (publ) | 10.75 Billion SEK | 99.637% |
| Scandinavian Real Heart AB (Publ) | 18.22 Million SEK | -114.296% |
| Iconovo AB (publ) | 63.35 Million SEK | 38.342% |
| Integrum AB (publ) | 90.57 Million SEK | 56.871% |
| Luxbright AB (publ) | 23.09 Million SEK | -69.173% |
| Mentice AB (publ) | 237.06 Million SEK | 83.522% |
| OssDsign AB (publ) | 175.6 Million SEK | 77.755% |
| Paxman AB (publ) | 133.8 Million SEK | 70.805% |
| Promimic AB (publ) | 48.55 Million SEK | 19.544% |
| Qlife Holding AB (publ) | 162.38 Million SEK | 75.944% |
| SciBase Holding AB (publ) | 69.97 Million SEK | 44.177% |
| ScandiDos AB (publ) | 61.03 Million SEK | 36.002% |
| Sedana Medical AB (publ) | 174.52 Million SEK | 77.618% |
| Senzime AB (publ) | 141.51 Million SEK | 72.397% |
| SpectraCure AB (publ) | 12.12 Million SEK | -222.089% |
| Stille AB | 87.21 Million SEK | 55.213% |
| Vitrolife AB (publ) | 5.56 Billion SEK | 99.298% |
| Xvivo Perfusion AB (publ) | 440.92 Million SEK | 91.141% |